High Uptake of ¹²³I-metaiodobenzylguanidine Related to Olfactory Neuroblastoma Revealed by Single-photon Emission CT

References

1. ↵
   Derdeyn CP, Moran CJ, Wippold II FJ, Chason DP, Koby MB, Rodriguez F. MRI of esthesioneuroblastoma. J Comput Assist Tomogr 1994;18:16-21

   CrossRefPubMed
2. ↵
   Ramsay HA, Kairemo KJA, Jekunen AP. Somatostatin receptor imaging of olfactory neuroblastoma. J Laryngol Otol 1996;110:1161-1163

   PubMed
3. ↵
   Lamszus K, Meyerhof W, Westphal M. Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas. J Neurooncol 1997;35:353-364

   CrossRefPubMed
4. ↵
   Wafelman AR, Hoefnagel CA, Maes RAA, Beijnen JH. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med 1994;21:545-559

   PubMed
5. ↵
   Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 1994;21:561-581

   PubMedWeb of Science
6. Lumbroso JD, Guermazi F, Hartmann O, et al. Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res 1988;271:689-705

   PubMed
7. Rufini V, Giordano A, Di Giuda D, et al. [¹²³I] MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med 1995;39 (suppl 4):25-28

   PubMed
8. Troncone L, Rufini V, Montemaggi P, Danza FM, Lasorella A, Mastrangelo R. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG) 5 years of experience. Eur J Nucl Med 1990;16:325-335

   CrossRefPubMed
9. ↵
   Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-1624

   Abstract/FREE Full Text
10. ↵
    Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D. Specific uptake of m-[¹²⁵I] iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res 1985;45:6366-6370

    Abstract/FREE Full Text
11. ↵
    Smets LA, Loesberg C, Janssen M, Metwally EA, Huiskamp R. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res 1989;49:2941-2944

    Abstract/FREE Full Text
12. ↵
    Gaze MN, Huxham IM, Mairs RJ, Barrett A. Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging. Int J Cancer 1991;47:875-880

    PubMed
13. ↵
    Leung A, Shapiro B, Hattner R, et al. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 1997;38:1352-1357

    Abstract/FREE Full Text
14. ↵
    Nakajo M, Shapiro B, Copp J, et al. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131] iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 1983;24:672-682

    Abstract/FREE Full Text
15. Paltiel HJ, Gelfand MJ, Elgazzar AH, et al. Neural crest tumors: I-123 MIBG imaging in children. Radiology 1994;190:117-121

    PubMed
16. ↵
    Bomanji J, Moyes J, Huneidi AHS, et al. Cerebral uptake of MIBG: adrenoceptors visualized? Nucl Med Commun 1991;12:3-13

    PubMed
17. Dwamena BA, Zempel S, Klopper JF, Van Heerden B, Wieland D, Shapiro B. Brain uptake of iodine-131 metaiodobenzylguanidine following therapy of malignant pheochromocytoma. Clin Nucl Med 1998;23:441-445

    CrossRefPubMed
18. ↵
    Goldsweig HG, Sundaresan N. Chemotherapy of recurrent esthesioneuroblastoma. Am J Clin Oncol 1990;13:139-143

    CrossRefPubMedWeb of Science
19. Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998;42:1029-1037

    CrossRefPubMedWeb of Science